Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Minerva Pediatr ; 65(2): 252, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23612273
2.
Minerva Pediatr ; 54(3): 217-20, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12070480

RESUMO

BACKGROUND: To investigate if high dose inhaled beclomethasone dipropionate started early after upper respiratory tract infection (URTI) could reduce recurrent wheezing in infants. METHODS: Twenty-six ambulatory infants, 7-12 months of age, with recurrent wheezing during upper respiratory tract infection participated. All experienced at least three wheezing attacks. Those with underlying lung or systemic disease were excluded. Infants were divided into two groups in an open unblinded manner, until 13 patients had been recruited for each group. The groups were similar in risk factors for recurrent wheezing. Four treatment periods of 5 days were planned for group 1. The dose regimen was nebulized beclomethasone 400 mg by mask tid for 5 days. Treatment was started at the very first sign of URTI prior to any sign of wheezing. Group 2 did not receive any preventive treatment and constituted the control group. Symptoms scores were recorded. The number of emergency room visits, hospital admissions and short courses with oral steroids was also noted. RESULTS: Twelve infants completed 48 treatment periods. Five visited the emergency room, only one during beclomethasone therapy. Six received oral steroids, two receiving beclomethasone. No patient was admitted to the hospital. Symptom scores were significantly lower during beclomethasone treatment (p<0.05). No apparent adverse events were reported. CONCLUSIONS: The infant with recurrent wheezing during URTI is a therapeutic challenge. Most of these infants have prodromal symptoms for about 24 hours before wheezing starts. In the present study we observed favorable results, decrease in the number the child wheezed and the number of acute attacks, when high dose inhaled beclomethasone is administered during this critical time.


Assuntos
Antiasmáticos/uso terapêutico , Beclometasona/uso terapêutico , Sons Respiratórios/etiologia , Infecções Respiratórias/complicações , Infecções Respiratórias/tratamento farmacológico , Administração por Inalação , Beclometasona/administração & dosagem , Criança , Esquema de Medicação , Feminino , Humanos , Masculino , Recidiva
3.
Pediatr Emerg Care ; 17(6): 444-6, 2001 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11753192

RESUMO

Jaw-thrust and bag-mask ventilation usually provide adequate oxygenation in patients with acute infectious upper-airway obstruction (AIUAO). It is the treatment of choice for patients on the way to hospital or in an emergency department until definitive stabilization is achieved with available resources. We report three fatal case studies showing ineffective bag-mask ventilation in AIUAO that raise concerns over this treatment. Case 1 is a 4-year-old patient with epiglottitis who suffered complete obstruction during transport to the hospital. Case 2 is a 3-year-old patient with epiglottitis who suffered complete obstruction during transport to the hospital. Case 3 is a 3-year-old child with viral laryngotracheitis and respiratory arrest just after the admission. Should the approach of bag-mask ventilation in AIUAO change to ventilate patients in the prone position? This approach offers two advantages. First, gravity helps the epiglottis fall forward, reducing the airway obstructions. Second, if the patient vomits during ventilation, the vomit will fall to the floor. During bag-mask ventilation in patients with severe partial airway obstruction, ventilation pressure is high. Gastric inflation may occur and rapidly distend the stomach. This gastric distension interferes with ventilation by elevating the diaphragm, resulting in a decreased lung volume. Cricoid pressure could prevent gastric distension in these instances and should be recommended.


Assuntos
Obstrução das Vias Respiratórias/terapia , Máscaras , Respiração Artificial/instrumentação , Respiração Artificial/métodos , Infecções Respiratórias/terapia , Pré-Escolar , Epiglotite/terapia , Humanos , Laringite/terapia , Laringite/virologia , Masculino , Decúbito Ventral , Traqueíte/terapia , Traqueíte/virologia
6.
Minerva Pediatr ; 44(7-8): 377-84, 1992.
Artigo em Italiano | MEDLINE | ID: mdl-1328836

RESUMO

The Authors describe the intraosseous administration of drugs and fluids in two patients: a preterm infant (gestational age 26 weeks, weight 850 g) with severe cardiopulmonary depression just after delivery, and a 15-day-old newborn with bronchopneumonia. The intraosseous infusion is safe and effective. At present, mainly in United States, it has an important role in pediatric emergency. It is indicated in all emergency situations where a vascular access must be rapidly obtained and in whom other methods of access to the vascular system have failed. After a short review on the history of this old procedure, used for the first time in 1922 for blood transfusions, the Authors describe its physiology, technique, complications, and contraindications.


Assuntos
Infusões Intraósseas , Bicarbonatos/administração & dosagem , Broncopneumonia/tratamento farmacológico , Emergências , Epinefrina/administração & dosagem , Feminino , Humanos , Recém-Nascido , Masculino , Sódio/administração & dosagem , Bicarbonato de Sódio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA